Authors/Disclosures
|
Aimee M. Aysenne, MD, MPH
(Tulane University, School of Medicine)
|
Dr. Aysenne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Aysenne has received stock or an ownership interest from Teledoc. Dr. Aysenne has received stock or an ownership interest from Pfizer. |
|
Dana L. McDermott, DO
(Montage Medical Group Specialty Services)
|
No disclosure on file |
|
|
No disclosure on file |
|
Tiffany Chang, MD
|
Dr. Chang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Football League. |
|
Sheryl Martin-Schild, MD, PhD, FAAN
(Dr. Brain, Inc.)
|
No disclosure on file |
|
Karen C. Albright, DO, DO, PhD, MS, MPH
(FDA)
|
Dr. Albright has nothing to disclose. |
|
Raul G. Nogueira, MD
(UPMC Stroke Institute)
|
Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |